Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,206 articles, preprints and more)

Search results

1-25 of 32 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth.
Bannoura SF, Aboukameel A, Khan HY, Uddin MH, Jang H, Beal EW, Thangasamy A, Shi Y, Kim S, Wagner KU, Beydoun R, El-Rayes BF, Philip PA, Mohammad RM, Saif MW, Al-Hallak MN, Pasche BC, Azmi AS
Cancer Lett, 604:217275, 24 Sep 2024
Cited by: 0 articles | PMID: 39321913
Add to export list
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.
Heath E, Dyson G, Ribeiro JR, Xiu J, Poorman K, Mamdani H, Al-Hallak MN, Shields AF, Elayoubi JA, Winer IS, Cackowski FC, Puckrein GA, Lopes GL, Jones N, Hauke RJ, Kareff SA, Radovich M, Sledge GW, Spetzler DB, [...] Marshall JL
Cancer Res Commun, 4(10):2598-2609, 01 Oct 2024
Cited by: 0 articles | PMID: 39172022 | PMCID: PMC11450693
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions.
Kim DW, Schram AM, Hollebecque A, Nishino K, Macarulla T, Rha SY, Duruisseaux M, Liu SV, Al Hallak MN, Umemoto K, Wesseler C, Cleary JM, Springfeld C, Neuzillet C, Joe A, Jauhari S, Ford J, Goto K
Future Oncol, 20(16):1057-1067, 13 Feb 2024
Cited by: 4 articles | PMID: 38348690
Add to export list
Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and Opportunities.
Cobani E, Al Hallak MN, Shields AF, Maier J, Kelly TE, Naidoo N, Tobon M, Kim S, Beal EW
J Gastrointest Cancer, 55(2):519-533, 05 Jan 2024
Cited by: 1 article | PMID: 38180678
Add to export list Review
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis
Bannoura SF, Aboukameel A, Khan HY, Uddin MH, Jang H, Beal E, Thangasamy A, Kim S, Wagner KU, Mohammad R, Al-Hallak MN, Pasche BC, Azmi AS
bioRxiv, 18 Dec 2023
Cited by: 0 articles | PPR: PPR775648
Add to export list Preprint
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.
Khan HY, Nagasaka M, Aboukameel A, Alkhalili O, Uddin MH, Bannoura SF, Mzannar Y, Azar I, Beal EW, Tobon ME, Kim SH, Beydoun R, Baloglu E, Senapedis W, El-Rayes BF, Philip PA, Mohammad RM, Shields AF, Al Hallak MN, Azmi AS
Mol Cancer Ther, 22(12):1422-1433, 01 Dec 2023
Cited by: 1 article | PMID: 37703579 | PMCID: PMC10690049
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.
Uddin MH, Al-Hallak MN, Khan HY, Aboukameel A, Li Y, Bannoura SF, Dyson G, Kim S, Mzannar Y, Azar I, Odisho T, Mohamed A, Landesman Y, Kim S, Beydoun R, Mohammad RM, Philip PA, Shields AF, Azmi AS
Clin Transl Med, 13(12):e1513, 01 Dec 2023
Cited by: 3 articles | PMID: 38131168 | PMCID: PMC10739156
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Primary Squamous Cell Biliary Carcinoma With Liver Metastasis Is Rare but Malicious.
Almujarkesh MK, Damughatla AR, Bathla J, Sugg K, LaBuda D, Alkassis S, Al Hallak MN
Gastroenterology Res, 16(5):276-279, 21 Oct 2023
Cited by: 0 articles | PMID: 37937226 | PMCID: PMC10627356
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset.
Nagasaka M, Brazel D, Baca Y, Xiu J, Al-Hallak MN, Kim C, Nieva J, Swensen JJ, Spetzler D, Korn WM, Socinski MA, Raez LE, Halmos B, Ou SI
Transl Oncol, 36:101744, 27 Jul 2023
Cited by: 5 articles | PMID: 37516008 | PMCID: PMC10410168
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers
Khan HY, Nagasaka M, Aboukameel A, Alkhalili O, Uddin MH, Bannoura S, Mzannar Y, Azar I, Beal E, Tobon M, Kim S, Beydoun R, Baloglu E, Senapedis W, El-Rayes B, Philip PA, Mohammad RM, Shields AF, Al-Hallak MN, Azmi AS
bioRxiv, 27 Mar 2023
Cited by: 0 articles | PPR: PPR636466
Add to export list Preprint
Aberrant transcription factors in the cancers of the pancreas.
Uddin MH, Al-Hallak MN, Philip PA, Chen H, El-Rayes B, Azmi AS
Semin Cancer Biol, 86(pt 2):28-45, 01 Sep 2022
Cited by: 1 article | PMID: 36058426
Add to export list Review
Correction to: Connecting the human microbiome and pancreatic cancer.
Sexton RE, Uddin MH, Bannoura S, Khan HY, Mzannar Y, Li Y, Aboukameel A, Al-Hallak MN, Al-Share B, Mohamed A, Nagasaka M, El-Rayes B, Azmi AS
Cancer Metastasis Rev, 41(2):333, 01 Jun 2022
Cited by: 0 articles | PMID: 35536453 | PMCID: PMC9486138
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers.
Khan HY, Nagasaka M, Li Y, Aboukameel A, Uddin MH, Sexton R, Bannoura S, Mzannar Y, Al-Hallak MN, Kim S, Beydoun R, Landesman Y, Mamdani H, Uprety D, Philip PA, Mohammad RM, Shields AF, Azmi AS
Cancer Res Commun, 2(5):342-352, 10 May 2022
Cited by: 10 articles | PMID: 35573474 | PMCID: PMC9105196
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Molecular profiling of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in cellular and LSL-Kras G12D/+; Trp53 fl/+; Pdx1-Cre (KPC) pancreatic cancer model
Uddin MH, Aboukameel A, Li Y, Khan HY, Sexton RE, Bannoura S, Dyson G, Al-Hallak MN, Mzannar Y, Mohamed A, Landesman Y, Kim S, Beydoun R, Mohammad RM, Shields AF, Azmi AS
bioRxiv, 09 Mar 2022
Cited by: 0 articles | PPR: PPR466988
Add to export list Preprint
Connecting the Human Microbiome and Pancreatic Cancer.
Sexton RE, Uddin MH, Bannoura S, Khan HY, Mzannar Y, Li Y, Aboukameel A, Al-Hallak MN, Al-Share B, Mohamed A, Nagasaka M, El-Rayes B, Azmi AS
Cancer Metastasis Rev, 41(2):317-331, 02 Apr 2022
Cited by: 5 articles | PMID: 35366155 | PMCID: PMC8976105
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Inhibitor of the nuclear transport protein XPO1 enhances the anticancer efficacy of KRAS G12C inhibitors in preclinical models of KRAS G12C mutant cancers
Khan HY, Nagasaka M, Li Y, Aboukameel A, Uddin MH, Sexton R, Bannoura S, Mzannar Y, Al-Hallak MN, Kim S, Beydoun R, Landesman Y, Mamdani H, Uprety D, Philip PA, Mohammad RM, Shields AF, Azmi AS
bioRxiv, 28 Jan 2022
Cited by: 0 articles | PPR: PPR447268
Add to export list Preprint
Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer.
Azar I, Alkassis S, Fukui J, Alsawah F, Fedak K, Al Hallak MN, Sukari A, Nagasaka M
Lung Cancer (Auckl), 12:103-114, 07 Oct 2021
Cited by: 12 articles | PMID: 34675733 | PMCID: PMC8507417
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC).
Nagasaka M, Asad MFB, Al Hallak MN, Uddin MH, Sukari A, Baca Y, Xiu J, Magee D, Mamdani H, Uprety D, Kim C, Xia B, Liu SV, Nieva JJ, Lopes G, Bepler G, Borghaei H, Demeure MJ, Raez LE, [...] Azmi AS
Lung Cancer, 160:92-98, 27 Aug 2021
Cited by: 5 articles | PMID: 34482103 | PMCID: PMC8853639
Add to export list Free full text in Europe PMC
Targeting KRAS in pancreatic cancer: new drugs on the horizon.
Bannoura SF, Uddin MH, Nagasaka M, Fazili F, Al-Hallak MN, Philip PA, El-Rayes B, Azmi AS
Cancer Metastasis Rev, 40(3):819-835, 09 Sep 2021
Cited by: 37 articles | PMID: 34499267 | PMCID: PMC8556325
Add to export list Review Free full text in Europe PMC
Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs.
Li Y, Al Hallak MN, Philip PA, Azmi AS, Mohammad RM
Cancers (Basel), 13(16):4161, 19 Aug 2021
Cited by: 14 articles | PMID: 34439315 | PMCID: PMC8392713
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus.
Mpilla GB, Uddin MH, Al-Hallak MN, Aboukameel A, Li Y, Kim SH, Beydoun R, Dyson G, Baloglu E, Senapedis WT, Landesman Y, Wagner KU, Viola NT, El-Rayes BF, Philip PA, Mohammad RM, Azmi AS
Mol Cancer Ther, 20(10):1836-1845, 12 Jul 2021
Cited by: 10 articles | PMID: 34253597 | PMCID: PMC8492493
Add to export list Free full text in Europe PMC
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer.
Nagasaka M, Uddin MH, Al-Hallak MN, Rahman S, Balasubramanian S, Sukari A, Azmi AS
Mol Cancer, 20(1):82, 01 Jun 2021
Cited by: 49 articles | PMID: 34074295 | PMCID: PMC8170728
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside.
Uddin MH, Al-Hallak MN, Philip PA, Mohammad RM, Viola N, Wagner KU, Azmi AS
Cancers (Basel), 13(11):2777, 03 Jun 2021
Cited by: 18 articles | PMID: 34204940 | PMCID: PMC8199777
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Gastrointestinal stromal tumor: a review of current and emerging therapies.
Al-Share B, Alloghbi A, Al Hallak MN, Uddin H, Azmi A, Mohammad RM, Kim SH, Shields AF, Philip PA
Cancer Metastasis Rev, 40(2):625-641, 19 Apr 2021
Cited by: 33 articles | PMID: 33876372
Add to export list Review
Gastric cancer: a comprehensive review of current and future treatment strategies.
Sexton RE, Al Hallak MN, Diab M, Azmi AS
Cancer Metastasis Rev, 39(4):1179-1203, 07 Sep 2020
Cited by: 295 articles | PMID: 32894370 | PMCID: PMC7680370
Add to export list Review Free full text in Europe PMC

1-25 of 32 results

1 2

Search life-sciences literature (45,104,206 articles, preprints and more)

Search results

RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth.

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.

The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions.

Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and Opportunities.

Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.

Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.

Primary Squamous Cell Biliary Carcinoma With Liver Metastasis Is Rare but Malicious.

Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset.

Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers

Aberrant transcription factors in the cancers of the pancreas.

Correction to: Connecting the human microbiome and pancreatic cancer.

Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers.

Molecular profiling of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in cellular and LSL-Kras G12D/+; Trp53 fl/+; Pdx1-Cre (KPC) pancreatic cancer model

Connecting the Human Microbiome and Pancreatic Cancer.

Inhibitor of the nuclear transport protein XPO1 enhances the anticancer efficacy of KRAS G12C inhibitors in preclinical models of KRAS G12C mutant cancers

Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer.

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC).

Targeting KRAS in pancreatic cancer: new drugs on the horizon.

Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs.

PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus.

Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer.

Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside.

Gastrointestinal stromal tumor: a review of current and emerging therapies.

Gastric cancer: a comprehensive review of current and future treatment strategies.

Partnerships & funding